Research programme: monoclonal antibody - Telephus Medical LLCAlternative Names: TPH 101
Latest Information Update: 12 Feb 2016
At a glance
- Originator Telephus Medical LLC
- Class Monoclonal antibodies
- Mechanism of Action Enzyme inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Osteomyelitis; Staphylococcal infections